Post-Induction low cardiac output syndrome (PiLCOs): a multicenter prospective observational study to identify Flow-Based early hypoperfusion in coronary artery bypass graft surgical patients

NCT ID NCT07810621

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 09, 2026

Summary

Hemodynamic change after induction of general anesthesia is usually judged from mean arterial pressure. Pressure, however, is a surrogate for flow, and the two can separate: cardiac output may fall while arterial pressure remains apparently adequate. The interval that follows induction of anesthesia, before surgical stimulation begins and while hemodynamic conditions are determined by anesthetic management alone, has not been characterized in terms of flow. This study is designed to define post-induction low cardiac output (PiLCOs) in patients undergoing coronary artery bypass grafting. This is a prospective, observational, two-centre cohort study. Consecutive adults undergoing isolated coronary artery bypass grafting with cardiopulmonary bypass at two tertiary cardiovascular surgery centre will be enrolled. No aspect of anesthetic or surgical management will be altered for the purposes of the study. An arterial catheter is sited before induction while the patient is awake, and cardiac index is recorded continuously at 30-second intervals by arterial waveform analysis. Mean arterial pressure, heart rate, stroke volume index and cardiac index are recorded at the same resolution. The analysis window is the 30 minutes that follow induction of anesthesia. The period of cardiopulmonary bypass is excluded from all analyses, because flow during bypass is generated by the pump rather than by the heart. The primary outcome has two components, both defined over that window and both referenced to a cardiac index threshold of 2.0 L/min/m2. The first is the total time spent below threshold, in minutes. The second is the cumulative low-output burden, defined as the integral over time of the difference between the threshold and the measured cardiac index, taken only where that difference is positive. Dimensional analysis reduces the unit of burden to L/m2, a body-surface-indexed volume of undelivered flow, which multiplied by body surface area yields an absolute flow deficit in liters. Time below threshold describes how long the exposure lasts and cumulative burden describes how deep it is. The two together define the exposure, and neither alone is sufficient. Secondary outcomes are the same two measures computed at cardiac index thresholds of 2.2 and 2.5 L/min/m2; the incidence of PiLCOs, defined as at least one measurement below 2.0 L/min/m2 within the window; the time-weighted average depth across the window and the median depth sustained while below threshold; the distribution of cumulative burden across the three consecutive ten-minute segments of the window; and the time from induction to the first measurement below threshold. Exploratory analyses will examine the association between the presence and the magnitude of PiLCOs and the postoperative course, including acute kidney injury, serum lactate, duration of mechanical ventilation, intensive care unit and hospital length of stay, and mortality. All outcome analyses are treated as exploratory and hypothesis-generating, and no adjustment is made for multiple comparisons. Sample size was derived from an internal pilot of 30 patients, comprising the first 15 consecutive patients enrolled at each centre. In that pilot the standard deviation of time below threshold was 8.14 min and the incidence of PiLCOs was 70.0%. Setting the half-width of the 95% confidence interval at 1.7 min for mean time below threshold requires 88 patients, and setting it at 9.5 percentage points for incidence requires 90; the larger figure was carried forward and rounded to 90, allocated as 45 patients per centre. Allowing 15% for withdrawal, protocol deviation and unusable recordings gives a planned enrollment of 104 patients. Because the study estimates the frequency and the magnitude of an event that has not previously been characterized, rather than testing a prespecified superiority hypothesis, sample size is based on the precision of estimation rather than on power.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 103 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults scheduled for isolated coronary artery bypass grafting with cardiopulmonary bypass at two tertiary cardiovascular surgery centre. Patients are approached before induction of anesthesia and enrolled consecutively. Every eligible patient during the enrollment period enters the cohort and no selection is applied.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Scheduled for elective or emergency cardiac or non-cardiac surgery under general anesthesia. * Availability of peri-operative cardiac output monitoring using the MostCare hemodynamic monitoring system, starting before induction of anesthesia and continuing during surgery. * Availability of required baseline preoperative clinical and laboratory data. * Written informed consent obtained from the participant or legally authorized representative. Exclusion Criteria: * Age under 18 years * Coronary artery bypass grafting combined with valve or aortic surgery * Preoperative mechanical circulatory support * Preoperative infusion of an inotrope or a vasopressor * Technical failure to establish arterial waveform monitoring before induction of anesthesia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia, general are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cardiac Output, Low coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    Ankara, Ankara, 06000, Turkey (Türkiye)

  • Ataturk University

    Erzurum, Erzurum, 25240, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.